AI healthcare company Presagen will be featured in two new international clinical studies at the prestigious European Society of Human Reproduction and Embryology (ESHRE) 2023 Annual Meeting in June 2023, in Copenhagen, Denmark. One is an independent study by the global fertility group IVI-RMA, which has over 70 fertility centers in 9 countries. The research was peer-reviewed and awarded an oral presentation. It shows that Life Whisperer’s AI can be effectively applied to post-thawed embryos, even though the AI was initially trained on pre-thawed embryos.
The second study was conducted with clinics across the globe including USA, SE Asia, Spain, and India. These studies provide further clinical evidence of the benefits of Presagen’s Life Whisperer suite of AI products to support IVF and fertility treatment. The aim is to improve outcomes for patients, including reducing the time and cost to achieve a successful IVF outcome.
Life Whisperer will also be exhibiting with its global distributor FujiFilm Irvine Scientific, which will have a major presence at the event as one of the dominant players in the fertility industry. Life Whisperer will be promoting its non-invasive, instant, low-cost and objective embryo assessment tools: Life Whisperer Viability, which assesses an embryo’s morphological quality, providing the likelihood of achieving a clinical pregnancy; and Life Whisperer Genetics, which provides an embryo’s likelihood of being genetically normal (euploid). These tools have been shown to reduce the time to pregnancy compared with current manual morphological grading, and thus improve success rates*. Life Whisperer is authorized for sale in 47 countries globally.
*Using simulated cohort ranking analyses.
The titles and summary of the research studies are:
Combined use of Artificial Intelligence (AI) algorithms for evaluating embryo viability and embryo genetics improves selection of embryos leading to clinical pregnancy
By Presagen/Life Whisperer (Australia, USA), Ovation (USA), Texas Fertility Centre (USA), Alpha IVF & Women’s Clinic (SE Asia), IVF-Spain (Spain), Wings IVF Women’s Clinic (India) (poster presentation)
Summary: The aim of the study was to determine the effect of time-point on performance of a non-invasive artificial intelligence (Life Whisperer AI) algorithm for evaluating embryo genetic status. The study found that while predictive ability was maintained across different time-points on day 5, optimal performance for ranking and selecting euploid embryos was observed at 120 hours post-fertilization.
Prediction of implantation of vitrified-warmed blastocysts using a deep learning algorithm on a single post-warming image of each embryo
By IVI-RMA Global (Oral presentation)
Summary: The aim of the study was to determine if a deep learning algorithm can predict the implantation likelihood of vitrified blastocysts from a single time-point post-warming time-lapse images obtained from EmbryoScope. The study found that there was a significant positive correlation between the score given by the deep learning algorithm (Life Whisperer) and the implantation rate of the frozen blastocysts analyzed.
Life Whisperer is a world-leader in the application of AI in IVF. The Life Whisperer Viability and Genetics AI-based embryo assessment tools are the first to be commercialized in a series of applications that encompass the complete IVF journey. Life Whisperer aims to improve IVF success rates at every point and, as a result, reduce time-to-pregnancy, making IVF more affordable and accessible to patients globally. Life Whisperer is being used in IVF clinics around the world.
Presagen is an AI healthcare company that is changing the way clinics, patients, and medical data from around the world are connected through AI. Its platform, The Social Network for Healthcare, connects clinics and patients globally, and enables collaboration and data sharing to create scalable AI healthcare products that are affordable and accessible for all. The decentralized network democratizes the creation of AI products, promotes collaboration through incentives, and protects data privacy and ownership. With a focus on improving Women’s Health outcomes globally, Presagen’s first product, Life Whisperer, is being used by IVF clinics globally to improve pregnancy outcomes for couples struggling with fertility. With a vision of creating the largest network of clinics, patients, and medical data from around the world, Presagen is driving the future of AI Enhanced Healthcare.
With a focus on improving Women’s Health outcomes globally, Presagen’s first product, Life Whisperer, is being used by IVF clinics globally to improve pregnancy outcomes for couples struggling with fertility. With a vision of creating the largest network of clinics, patients, and medical data from around the world, Presagen is driving the future of AI Enhanced Healthcare.